Reaction of Naphthoquinones with
Abstract-We report here a simple entry into naphtho[2, 3-d] isoxazole-4,9-dione system containing a EWG in position 3 using the readily available 2,3-dichloro-1,4-naphthoquinone and nitromethyl derivatives in the presence of base. Antifungal activity of synthesised naphthoquinones was evaluated against ATCC and PYCC reference strains of Candida. The results suggest that the naphtho[2, 3-d] isoxazole-4,9-dione scaffold has the potential to be developed into novel and safe therapeutic antifungal agents.
Compounds containing the quinone group represent an important class of biologically active molecules that are widespread in nature. 1 Isoxazoles also have a significant number of biological applications, displaying hypoglycemic, analgesic, antiinflammatory, antifungal, anti-bacterial and HIVinhibitory activity.
2 Naphtho[2, 3-d] isoxazole-4,9-diones 1 ( Figure 1 ) combine both functionalities and are an attractive target. Importantly, compounds 1 also display agricultural applications. To date, most of the routes to naphtho[2, 3-d] isoxazole-4,9-diones described in the literature use in situ generation of nitrile oxides, require the synthesis of the necessary starting materials and do not allow the introduction of electron-withdrawing group (EWG) in position 3. [4] [5] [6] To the best of our knowledge, there is only one route that introduces an ethyl ester in position 3 of the isoxazole moiety that involves a manganese (III) acetate initiated reaction between readily available 1,4-naphthoquinones and ethyl nitroacetate. This method is highly wasteful, requiring 8 eq. of ethyl nitroacetate and 12 eq. of manganese (III) acetate. 7, 8 Recently we described naphtho[2, 3-d] isoxazole-4,9-dione-3-carboxylates 1a-b as potent, non-cytotoxic, antiapoptotic agents, through modulation of apoptotic pathways. 9 The two compounds were synthesized from 1 eq. of each commercially available starting material, 2,3-dichloro-1,4-naphthoquinone 2 and a nitromethyl derivative 3a-b, in the presence of base (Scheme 1). By this method, the isoxazole 1a was obtained in 22% yield (35% based on recovered 2) after 3d at reflux in the presence of NEt 3 in ethanol. Using methyl nitroacetate 3b the isoxazole 1b was obtained in 19% yield, along with the isoxazole 1a (7% yield) due to ester exchange, and 2-chloro-3-ethoxy-1,4-naphthoquinone 4a (13% yield). To avoid the problem of ester exchange, we changed the solvent to MeOH but did not observe any formation of isoxazole after 3d at reflux (Table 1) . In this case, we only isolated 2-chloro-3-methoxy-1,4-naphthoquinone 4b (33% yield) -presumably due to the lower temperature of reflux.
We then decided to continue working on this new methodology in order to improve the low yields of naphtho[2, 3-d] isoxazole-4,9-dione-3-carboxylates 1a-b. An improved synthesis was accomplished, using diisopropylethylamine (2 eq.) as base, in the presence of molecular sieves.
10a In this case, the reaction When 2-bromo-1,4-naphthoquinone 5 was used as starting material, naphthoquinone 6 (78% yield) was obtained from reaction with 3a, after 6.5h at reflux in the presence of NEt 3 in ethanol (Scheme 2). Only after 29h at reflux, was the isoxazole 1a obtained (13% yield), along with the naphthoquinone 6 (26% yield). 12, 13 The latter obviously arises from Michael addition of the nitronate anion at the least substituted quinone carbon atom followed by loss of the nitrite ion. Attack at the C-H carbon is presumably preferred because (i) this centre is less sterically hindered, and (ii) bromine stabilizes an adjacent anion better than does an H atom. When we used 2,3-dichloro-5,8-dimethoxy-1,4-naphthoquinone 7 and 3a as starting materials, after 1.5h at reflux in ethanol in the presence of 2 eq. of DIEA and molecular sieves, we isolated compound 8 in 56% yield (Scheme 2).
14 In this case, no formation of isoxazole was observed, even after 30 h at reflux in the presence of NEt 3 (Table 1 ).
This method seems to be general for other nitromethyl derivatives, as it was also possible to obtain naphtho[2, 3-d] isoxazole-4,9-diones with a sulfone 1c and a ketone 1d in position 3 (Scheme 1). When reaction of 2 was attempted with phenylsulfonylnitromethane 3c or benzoylnitromethane 3d in the presence of DIEA and ethanol, only 2-chloro-3-ethoxy-1,4-naphthoquinone 4a, from reaction of the quinone with the solvent, could be isolated (Table  1) .
10a However, when we changed the solvent to acetonitrile, it was then possible to obtain the isoxazoles 1c and 1d, respectively (Table 1).   10b Isoxazole 1c was only formed in the presence of NEt 3 (10% yield). In the presence of DIEA or K 2 CO 3 a complex mixture of products was obtained. Isoxazole 1d however was obtained using as bases DABCO (12% yield), NEt 3 (32% yield), DIEA (32% yield) or K 2 CO 3 (23% yield). To try to improve the yield of 1d, we decided to study the effect of using 2 equivalents of nitroacetate 3d, however in the presence of NEt 3 in CH 3 CN, we obtained a more complex mixture, and we could only isolate isoxazole 1d in 14% yield. In all the above reactions, a complex mixture of products was obtained, and we could only isolate as the major products the products described in table 1.
Structural assignment of products 1 was based on spectroscopic data, [16] [17] which accorded with the literature. 7 Confirmation of the isoxazole structure 1 came from the X-ray crystallographic analysis. 18 Naphtho[2, 3-d] isoxazole-4,9-diones 1a-d and naphthoquinones 4a-b, 6 and 8 were evaluated for their antifungal activity against various ATCC and PYCC reference strains of Candida. 19 The MIC 50 values were calculated using probit analysis based on triplicate assays and are presented in Table 2 . All compounds showed a reasonable level of antifungal activity at the µg/mL level, ranging from the lowest MIC 50 value of 0.2 µg/mL for compound 1a against PYCC 2545 (C. parapsilosis) and PYCC 2418 T (C. glabrata) to the highest of 47.9 µg/mL for compound 4a against ATCC 90028 (C. albicans). Inspection of the data in Table 2 , allows the following observations to be made: 1.
There was marked variability among the strains with regard to their susceptibilities to the various test compounds. This is particularly evident for the C. albicans ATCC 90028 and PYCC 3436T strains (e.g. compounds 1c, 1d and 4a). Such variability suggests there are biological factor(s) affecting strain/species and test compound bioactivity.
2.
Strain ATCC 90028 appeared to be the least sensitive, to almost all the compounds. Only compound 6, with an MIC 50 of 1.5 µg/mL demonstrated antifungal activity equivalent to that of AmpB (Amphotericin B) for this strain. In addition, this compound also had notable activity against PYCC strains 2545 and 3436 T .
3.
Only compounds 1a and 1b showed a level of activity equivalent to that of AmpB against strain ATCC 22019. 
4.
The order of the antifungal activity in compounds 1 seems to depend on the nature of the EWG in position 3 and varies in the order ester › sulfone › ketone.
5.
Compounds 1d, 4a and 4b, also showed reasonable antifungal activities equivalent to that of AmpB against one strain, each. Compound 8, although exhibiting fair antifungal activity at the µg/mL level against all strains, did not present any MIC 50 values at or below that of AmpB against any of the strains.
In summary, we describe a new methodology for the synthesis of isoxazoles 1 containing an EWG in position 3. Although the yields are lower than those described for the synthesis of isoxazole 1a (lit. 55% yield), 7 our procedure uses cleaner chemistry and only 1 equivalent of both commercial starting materials. Also, our method is not restricted to the use of ethyl nitroacetate, but seems to be general for other nitromethyl derivatives. In addition, all the test compounds showed effective levels of antifungal activity at the µg/mL level. Importantly, 1a and 1b showed the broadest activity and were equivalent to or better than the standard antifungal drug Amphotericin B against five of the six strains examined. The observation that naphtho[2, 3-d] isoxazole-4,9-dione-3-carboxylates 1a-b are non-cytotoxic in human cellular lines 9 strongly suggests that the naphtho[2, 3-d] isoxazole-4,9-dione scaffold has the potential to be developed into novel and safe therapeutic antifungal agents. The mechanism for the formation of isoxazoles 1a-d is understudy.
